Safety and efficacy of amrubicin monotherapy in patients with platinum-refractory metastatic neuroendocrine carcinoma of the gastrointestinal tract: a single cancer center retrospective study

PURPOSE: Patients with gastrointestinal neuroendocrine carcinoma (GI-NEC) have poor prognoses. Although platinum-based combination chemotherapy is commonly used as first-line treatment, the benefit of amrubicin (AMR) and salvage chemotherapy in those who develop platinum-refractory GI-NEC remains un...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Manag Res
Auteurs principaux: Kitagawa, Yusuke, Osumi, Hiroki, Shinozaki, Eiji, Ota, Yumiko, Nakayama, Izuma, Suzuki, Takeshi, Wakatsuki, Takeru, Ichimura, Takashi, Ogura, Mariko, Ooki, Akira, Takahari, Daisuke, Suenaga, Mitsukuni, Chin, Keisho, Yamaguchi, Kensei
Format: Artigo
Langue:Inglês
Publié: Dove 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6599893/
https://ncbi.nlm.nih.gov/pubmed/31417315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CMAR.S201048
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires